BMC Geriatrics,
Journal Year:
2022,
Volume and Issue:
22(1)
Published: June 30, 2022
Abstract
Background
The
increased
risk
of
adverse
drug
reactions
due
to
age-related
altered
pharmacokinetics
and
pharmacodynamics
is
a
challenge
when
prescribing
medications
older
people,
especially
among
people
with
major
neurocognitive
disorder
who
are
particularly
sensitive
effects.
aim
this
study
was
investigate
the
use
potential
inappropriate
(PIMs)
in
2012
2017
old
disorder.
A
secondary
factors
associated
PIM
use.
Methods
This
register-study
based
on
Swedish
registry
for
cognitive/dementia
disorders
prescribed
register.
Criteria
from
National
Board
Health
Welfare
were
used
identify
PIMs
between
1
July–31
December
July-–31
≥
65
years.
Drug
defined
as
one
or
more
filled
prescriptions
during
each
timeframe.
Results
total
declined
significantly
(28.7%)
(21.7%).
All
groups
these
years,
except
antipsychotic
drugs,
which
11.6%
12.3%.
results
multiple
regression
model
found
that
younger
age
(OR:
0.97
CI:
0.96–0.97),
lower
Mini
Mental
State
Examination
score
0.99
0.99–1.00),
multi-dispensed
drugs
2.05
1.93–2.18),
compared
Alzheimer’s
disease,
subtypes
dementia
Lewy
bodies
Parkinson’s
disease
1.57
1.40–1.75),
frontotemporal
1.29
1.08–1.54)
vascular
1.10
1.03–1.16).
Conclusions
Overall,
decreased
years
2017.
increase
association
warrant
concern.
British Journal of General Practice,
Journal Year:
2022,
Volume and Issue:
72(715), P. e91 - e98
Published: Jan. 24, 2022
Background
Higher
continuity
of
GP
care
(CGPC),
that
is,
consulting
the
same
doctor
consistently,
can
improve
doctor–patient
relationships
and
increase
quality
care;
however,
its
effects
on
patients
with
dementia
are
mostly
unknown.
Aim
To
estimate
associations
between
CGPC
potentially
inappropriate
prescribing
(PIP),
incidence
adverse
health
outcomes
(AHOs)
in
dementia.
Design
setting
A
retrospective
cohort
study
1
year
follow-up
anonymised
medical
records
from
9324
dementia,
aged
≥65
years
living
England
2016.
Method
measures
include
Usual
Provider
Care
(UPC),
Bice–Boxerman
Continuity
(BB),
Sequential
(SECON)
indices.
Regression
models
estimated
PIPs
survival
analysis
AHOs
during
adjusted
for
age,
sex,
deprivation
level,
14
comorbidities,
frailty.
Results
The
highest
quartile
(HQ)
UPC
(highest
continuity)
had
34.8%
less
risk
delirium
(odds
ratio
[OR]
0.65,
95%
confidence
interval
[CI]
=
0.51
to
0.84),
57.9%
incontinence
(OR
0.42,
CI
0.31
0.58),
9.7%
emergency
admissions
hospital
0.90,
0.82
0.99)
compared
lowest
quartile.
Polypharmacy
PIP
were
identified
81.6%
(
n
7612)
75.4%
7027)
patients,
respectively.
HQ
fewer
prescribed
medications
(HQ:
mean
8.5,
(LQ):
9.7,
P
<0.01)
2.1,
LQ:
2.5,
<0.01),
including
loop
diuretics
incontinence,
drugs
cause
constipation,
benzodiazepines
high
fall
risk.
BB
SECON
produced
similar
findings.
Conclusion
was
associated
safer
lower
rates
major
events.
Increasing
may
help
treatment
outcomes.
Journal of the American Geriatrics Society,
Journal Year:
2021,
Volume and Issue:
69(9), P. 2464 - 2475
Published: June 8, 2021
Abstract
Background/objectives
In
older
persons
with
dementia
(PWD),
extensive
medication
use
is
often
unnecessary,
discordant
goals
of
care,
and
possibly
harmful.
The
objective
this
study
was
to
determine
the
prevalence
constituents
polypharmacy
among
PWD
attending
outpatient
visits
in
United
States.
Design
Cross‐sectional
analysis.
Setting
participants
without
(PWOD)
aged
≥65
years
recorded
nationally
representative
National
Ambulatory
Medical
Care
Survey
(NAMCS),
2014–2016.
Measurements
were
identified
as
those
a
diagnosis
on
NAMCS
encounter
form
and/or
receiving
an
anti‐dementia
medication.
Visits
PWOD
compared
terms
sociodemographic,
practice/physician
factors,
comorbidities,
prescribing
outcomes.
Regression
analyses
examined
effect
contributions
by
clinically
relevant
categories
(defined
being
prescribed
≥5
prescription
nonprescription
medications).
Results
unweighted
sample
involved
918
for
26,543
PWOD,
representing
29.0
780
million
visits.
had
median
age
81
average
2.8
comorbidities
other
than
dementia;
63%
female.
number
medications
eight
three
(
p
<
0.001).
After
adjustment,
significantly
higher
odds
(AOR
3.0;
95%
CI:
2.1–4.3)
or
≥10
2.8;
2.0–4.2)
PWOD.
largest
sources
cardiovascular
central
nervous
system
medications;
usage
from
generally
elevated
at
least
one
highly
sedating
anticholinergic
2.5;
1.6–3.9).
Conclusion
visits,
extremely
common
PWD,
driven
wide
array
categories.
Addressing
will
require
cross‐cutting
multidisciplinary
approaches.
Frontiers in Pharmacology,
Journal Year:
2023,
Volume and Issue:
14
Published: Aug. 24, 2023
Background:
Older
patients
with
dementia
always
need
multiple
drugs
due
to
comorbidities
and
cognitive
impairment,
further
complicating
drug
treatment
increasing
the
risk
of
potentially
inappropriate
medication.
The
objective
our
study
is
estimate
global
prevalence
polypharmacy
medication
(PIM)
explore
factors
PIM
for
older
dementia.
Methods:
We
searched
PubMed,
Embase
(Ovid),
Web
Science
databases
identify
eligible
studies
from
inception
16
June
2023.
conducted
a
meta-analysis
observational
reporting
in
using
random-effect
model.
associated
were
meta-analyzed.
Results:
Overall,
62
included,
which
53
reported
28
polypharmacy.
pooled
was
43%
(95%
CI
38–48)
62%
52–71),
respectively.
Sixteen
referred
use,
15
pooled.
Polypharmacy
(2.83,
95%
1.80–4.44),
diabetes
(1.31,
1.04–1.65),
heart
failure
(1.17,
1.00–1.37),
depression
(1.45,
1.14–1.88),
history
cancer
(1.20,
1.09–1.32),
hypertension
(1.46,
1.05–2.03),
ischemic
disease
(1.55,
0.77–3.12),
any
cardiovascular
(1.11,
1.06–1.17),
vascular
(1.09,
1.03–1.16),
chronic
obstructive
pulmonary
(1.39,
1.13–1.72),
psychosis
(1.91,
1.04–3.53)
are
positively
use.
Conclusion:
highly
prevalent
Among
different
regions,
use
varied
widely.
Increasing
closely
For
other
such
as
diabetes,
prescribing
should
be
cautioned.
International Journal of Environmental Research and Public Health,
Journal Year:
2022,
Volume and Issue:
19(5), P. 2637 - 2637
Published: Feb. 24, 2022
The
aim
of
this
study
was
to
evaluate
the
prevalence
polypharmacy
and
potentially
inappropriate
medications
(PIMs)
in
a
population
older
adults
living
nursing
homes.
Furthermore,
we
also
intended
assess
possible
association
between
polypharmacy,
cognitive
impairment
institutionalized
adults.
A
cross-sectional
analyzed
data
from
193
home
residents
district
Viseu,
Portugal,
September
2018
June
2019,
with
mean
age
82.4
±
6.2
years
(ranging
65
95
old);
72.5%
(n
=
140)
were
female
participants.
Major
presented
80.8%
population,
who
took
7.6
3.3
drugs
per
day.
Using
Beers
Criteria,
found
that
79.3%
PIMs.
There
positive
PIM
(p
<
0.001),
showing
higher
medicines
intake
increased
number
Polypharmacy
not
associated
functionality
perform
activities
daily
living,
but
impairment.
lower
scores
on
Mini
Mental
State
Examination
(MMSE)
more
0.039)
used
0.001).
Moreover,
patients
taking
five
or
prescription
day
(major
polypharmacy)
consuming
any
psychiatric,
gastrointestinal
oral
antidiabetic
agents
(regardless
whether
they
considered
not)
had
odds
displaying
than
those
did
0.05).
Older
adult
studied
homes
affected
by
polypharmacy.
This
observation
reveals
need
adopt
implement
strategies
make
drug
therapy
adequate
safer
for
Journal of the American Medical Directors Association,
Journal Year:
2025,
Volume and Issue:
26(4), P. 105474 - 105474
Published: Feb. 7, 2025
Psychotropic
drugs
are
frequently
prescribed
for
challenging
behavior
in
residents
with
dementia
nursing
homes.
Recommendations
on
psychotropic
drug
use
described
the
Dutch
multidisciplinary
guideline
"Problem
dementia."
This
study
aimed
to
gain
insight
into
adherence
recommendations
type
and
timing
of
evaluations
different
types
a
national
sentinel
network
Prospective
observational
study.
Data
22
homes
across
Netherlands
were
collected
during
3-month
measurement
period
2021.
Physicians
completed
registration
forms
integrated
electronic
health
record
after
reporting
progress
notes.
Prescribed
type(s),
intervention
(start/stop/change
dosage/evaluation),
indications
recorded.
Adherence
was
achieved
if
recommended
specified
indication.
reported
within
7
days
starting.
A
total
1279
behaviors
599
collected.
Recommended
used
57%
all
forms.
The
highest
rate
psychotic
(80%),
followed
by
agitation
(48%).
lowest
nighttime
restlessness
(22%).
Of
newly
started
prescriptions,
17%
evaluated
present
just
over
half
cases.
Frequently,
not
or
performed
time
frame.
Further
research
is
needed
determine
reasons
non-recommended
use,
low
evaluation
rates,
factors
that
influence
adherence.
may
increase
awareness
BMC Geriatrics,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: Feb. 27, 2025
In
persons
with
dementia,
polypharmacy
may
be
discordant
the
goals
of
care.
It
is
necessary
to
design
interventions
that
align
treatment
regimens
patient's
situation,
prognosis
and
preferences.
The
objectives
this
study
conducted
at
an
intermediate
care
were
to:
i)
identify
inappropriate
prescribing
per
main
goal;
ii)
compare
pharmacotherapy
data
pre
post
a
medication
review
based
on
degree
cognitive
impairment;
iii)
assess
implementation
proposed
recommendations
three
months
after
discharge.
Pre-post
quasi-experimental
study.
Patients
dementia
discharged
from
hospital
between
November
2021
April
2022.
Demographic,
clinical
evaluated
admission.
Medication
reviews
interviews
caregivers
pharmacologic
therapies
overall
At
discharge,
information
was
shared
primary
team
in
discharge
summary.
Follow
up
evaluate
during
performed
months.
Of
97
patients
included,
94.8%
had
least
one
inappropriately
prescribed
medication.
mean
number
chronic
medications
taken
patient
decreased
by
29.6%,
8.05(SD
3.5)
5.67(SD
2.7)
(p
<
0.001);
anticholinergic
burden
18.6%,
1.59(SD
1.0)
1.29(SD
0.9)
therapeutic
complexity
28.4%,
29.23(SD
13.8)
20.94(SD
11.3)
0.001).
3
90.0%.
Admission
provides
ideal
setting
for
multicomponent
intervention,
tailoring
prescriptions
preferences,
improving
parameters
related
side
effects,
ensuring
are
maintained
over
medium
term.
Implementation Science Communications,
Journal Year:
2021,
Volume and Issue:
2(1)
Published: Dec. 1, 2021
Abstract
Background
The
importance
of
providing
evidence-based
palliative
care
for
people
with
dementia
is
increasingly
acknowledged
as
important
patient
outcomes.
In
Ireland,
guidance
has
been
developed
in
order
to
address
key
features
care,
including
the
management
pain,
medications
and
hydration
nutrition.
aim
this
study
was
identify
explore
factors
affecting
implementation
on
care.
Methods
Consolidated
Framework
Implementation
(CFIR)
guided
a
mixed-method
pre-post
study.
One
document
pertaining
medication
or
nutrition
implemented
three
long-term
facilities.
Participatory
action
research
form
work-based
learning
groups
used
implement
guidance,
drawing
situational
analysis
(pre-implementation).
Staff
questionnaires
audits
were
conducted
pre-
post-implementation
while
champion
interviews
also
post-implementation.
Results
Features
inner
setting
components
such
readiness
change,
process
most
frequently
identified
impacting
implementation.
Components
outer
setting,
external
policy
incentives
individual
characteristics,
featured
less
commonly.
Data
from
qualitative
revealed
that
perceived
advantageous
complimentary
previous
provided.
Within
leadership
support
other
colleagues
facilitated
However,
limited
availability
healthcare
professionals
assist
carrying
out
actions
presented
barrier
some
facilitators
(WBLGs)
experienced
encouraged
active
participation
reflection
practices.
Despite
challenge
releasing
staff
attend
WBLGs,
quantitative
data
demonstrated
reduced
de-motivation
amongst
those
who
did
noted
(pre-
Mdn
=
19.50
versus
post-
22.00,
U
497.00,
p
0.07).
Conclusions
A
informed
by
CFIR
framework
conjunction
participatory
approach
helped
advance
guidance.
progress
depended
extent
which
previously
being
at
each
site.
Post-implementation
using
challenges
future
projects
cover
timing
training
facilitate
attendance
different
working
hours.
Facilitators
included
multidisciplinary
engagement
intervention
champions
site
process.
International Journal of Environmental Research and Public Health,
Journal Year:
2022,
Volume and Issue:
19(18), P. 11426 - 11426
Published: Sept. 10, 2022
The
objective
of
this
study
was
to
characterize
the
epidemiology
using
potentially
inappropriate
medications
associated
with
dementia
exacerbation
(DPIMs)
in
elderly
outpatients
dementia.
Electronic
medical
records
were
retrospectively
reviewed
for
geriatric
patients
who
prescribed
at
least
one
medication
2016
a
tertiary,
university-affiliated
hospital.
2015
Beers
criteria
used
define
DPIMs.
Logistic
regression
performed
identify
factors
prescribing
DPIMs
Among
2100
included
our
study,
987
(47.0%)
DPIM.
Benzodiazepines
most
frequently
DPIM
followed
by
anticholinergics,
histamine
H2-receptor
blockers,
and
zolpidem.
risk
significantly
increased
female
(odds
ratio
(OR)
1.355)
polypharmacy
(OR
5.146)
multiple
comorbidities
1.129)
(p
<
0.05
all).
Coexistence
Parkinson’s
disease
1.799),
mood
disorder
1.373),
or
schizophrenia
4.116)
further
likelihood
receiving
In
conclusion,
commonly
Korea
benzodiazepines
anticholinergics.
Female
should
be
closely
monitored
minimize
unnecessary
use
and,
ultimately,
DPIM-related
harms.
American Journal of Speech-Language Pathology,
Journal Year:
2023,
Volume and Issue:
32(5), P. 2146 - 2157
Published: July 12, 2023
The
primary
purpose
of
this
study
was
to
obtain
preliminary
evidence
for
a
communication
coaching
intervention,
Dementia
Collaborative
Coaching.
secondary
aim
assess
the
acceptability,
appropriateness,
and
feasibility
intervention
according
routine
care
providers.